RUBIN PAUL D — SEC Form 4 filings
SEC reporting owner CIK 1210905. 8 Form 4 filings on record with FilingPulse; latest filed 2026-04-03.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2025-02-20 to 2026-04-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 6 legs across 6 filings — 118,016 shares, $1,460,742 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
- Largest priced transaction: sale of 68,897 shares @ $10.19 ($701,909) in BioAge Labs, Inc., filed 2025-12-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BioAge Labs, Inc. (BIOA) | Chief Medical Officer | 8 | — | 6 legs · 118,016 sh · $1,460,742 | 22 |
Form 4 filings — RUBIN PAUL D
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-03 | 4 | BioAge Labs, Inc. (BIOA) | Option exercise (M): 5,437 @ $4.11 · Option exercise (M): 3,383 @ $6.57 · Sale (S): 8,820 @ $17.81 · Option exercise (M): 5,437 (derivative) @ $0 · Option exercise (M): 3,383 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | BioAge Labs, Inc. (BIOA) | Option exercise (M): 5,433 @ $4.11 · Option exercise (M): 2,000 @ $6.57 · Sale (S): 7,433 @ $20.30 · Option exercise (M): 5,433 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | BioAge Labs, Inc. (BIOA) | Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | BioAge Labs, Inc. (BIOA) | Option exercise (M): 5,433 @ $4.11 · Option exercise (M): 2,000 @ $6.57 · Sale (S): 7,433 @ $18.75 · Option exercise (M): 5,433 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | BioAge Labs, Inc. (BIOA) | Option exercise (M): 5,433 @ $4.11 · Option exercise (M): 2,000 @ $6.57 · Sale (S): 7,433 @ $12.85 · Option exercise (M): 5,433 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2025-12-11 | 4 | BioAge Labs, Inc. (BIOA) | Option exercise (M): 18,000 @ $6.57 · Sale (S): 18,000 @ $12 · Option exercise (M): 18,000 (derivative) @ $0 | EDGAR |
| 2025-12-05 | 4 | BioAge Labs, Inc. (BIOA) | Option exercise (M): 68,897 @ $4.11 · Sale (S): 68,897 @ $10.19 · Option exercise (M): 68,897 (derivative) @ $0 | EDGAR |
| 2025-02-20 | 4 | BioAge Labs, Inc. (BIOA) | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1210905 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →